Clinical sources and antimicrobial susceptibility of Prevotella timonensis at the university hospital of Montpellier, France

被引：3

作者：

Aberkane, Salim ^{[1
,2
,3
]}

Pradel, Baptiste ^{[1
,2
]}

Dumont, Yann ^{[1
,2
]}

Veloo, Alida C. M. ^{[5
]}

Laurens, Chrislene ^{[1
]}

Bonzon, Lucas ^{[1
,2
]}

Godreuil, Sylvain ^{[1
,2
,3
]}

Marchandin, Helene ^{[1
,4
]}

Jean-Pierre, Helene ^{[1
,4
]}

机构：

[1] Ctr Hosp Reg Univ CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France

[2] Univ Montpellier, Montpellier, France

[3] INSERM, U1058, Montpellier, France

[4] Univ Montpellier, UMR 5569, Equipe Pathogenes Hydr Sante Environm, Montpellier, France

[5] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands

来源：

ANAEROBE | 2018年 / 50卷

关键词：

Prevotella timonensis; France; Antimicrobial resistance; Clinical relevance; Anaerobic bacteria; IDENTIFICATION; NOV;

D O I：

10.1016/j.anaerobe.2018.01.002

中图分类号：

Q93 [微生物学];

学科分类号：

071005 [微生物学];

摘要：

We describe 84 clinical isolates of Prevotella timonensis recovered between January 2007 and November 2016 at the University Hospital of Montpellier. They were recovered from a variety of clinical samples, mostly of genital and wound origins. All isolates were isolated from a mixed aerobic and anaerobic microbiota. Antimicrobial susceptibility testing of 50 isolates showed 56% of beta-lactamase production and 40% of resistance to clindamycin. One strain was resistant to metronidazole. (C) 2018 Elsevier Ltd. All rights reserved.

引用

页码：19 / 21

页数：3

共 7 条

[1]

Carlier JP, 2002, INT J SYST EVOL MICR, V52, P983, DOI 10.1099/00207713-52-3-983

[2]

β-lactamase production in Provotella and in vitro susceptibilities to selected β-lactam antibiotics [J].